Strassenburg Pharmaceuticals

Strassenburg Pharmaceuticals Ltd., established in 1987, is a prominent pharmaceutical company headquartered in India, focusing on delivering accessible and superior quality medications to the Indian populace. Operating within the Healthcare and Pharmaceuticals sectors, the company is dedicated to addressing critical therapeutic needs. Its core specializations encompass Gastrointestinal disorders, effective Pain Management strategies, and advanced Topical Wound Healing solutions. Strassenburg Pharmaceuticals is built on pillars of innovation, unwavering quality, and profound trust within the healthcare ecosystem.

With a substantial workforce exceeding 800 professionals, Strassenburg Pharmaceuticals maintains a significant operational footprint. The company actively engages with a vast network comprising 80,000 doctors and 1,500 distributors, underscoring its extensive reach across the nation. To gain insights into the individuals driving this mission, you can explore Meet Strassenburg Pharmaceuticals' team. This extensive network and dedicated team facilitate the company's mission to improve patient outcomes through reliable pharmaceutical products.

The company's product portfolio features highly recognized brands, including Sucral, which holds the distinction of being India's leading Sucralfate brand, and Parasafe, a top-tier Paracetamol brand. Strassenburg Pharmaceuticals generates an annual revenue of $56.9M, reflecting its market presence and operational success. The company's commitment to excellence ensures that it continues to be a trusted name in Indian healthcare, consistently striving to meet the evolving medical needs of its patient base.